A detailed history of Abbot Financial Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Abbot Financial Management, Inc. holds 228 shares of LLY stock, worth $181,494. This represents 0.1% of its overall portfolio holdings.

Number of Shares
228
Previous 228 -0.0%
Holding current value
$181,494
Previous $206,000 2.43%
% of portfolio
0.1%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $165,270 - $207,261
228 New
228 $206,000
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $53,896 - $69,772
-328 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$106.92 - $132.43 $35,069 - $43,437
328 New
328 $43,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Abbot Financial Management, Inc. Portfolio

Follow Abbot Financial Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbot Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abbot Financial Management, Inc. with notifications on news.